Solid phase synthesis of a biased mini tetrapeptoid-library for the discovery of monodentate itam mimics as ZAP-70 inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 5, 1998, Pages 405-408

  Révész, Laszlo ^a   Bonne, Frédérique ^a   Manning, Ute ^a   Zuber, Jean Francois ^a  

^a Preclinical Research   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; PHOSPHOTYROSINE; UNCLASSIFIED DRUG; ZAP 70 ANTAGONIST;

ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG SYNTHESIS; NONHUMAN; SOLID PHASE EXTRACTION;

HUMANS; MOLECULAR MIMICRY; OLIGOPEPTIDES; PEPTIDE LIBRARY; PROTEIN-TYROSINE KINASES; RECEPTORS, IMMUNOLOGIC; SRC HOMOLOGY DOMAINS; TYROSINE; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 0032478162     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00043-2     Document Type: Article

References (12)

1. (1) Pawson, T. and Schlessinger, J. Current Biology 1993, 3, 434, and references therein.
2. (2) Wange R.L.; Isakov, N.; Burke, T.R.; Otaka, A.; Roller, P.P.; Watts, J.D.; Aebersold, R. and Samelson, L.E. J.Biol.Chem. 1995, 270, 944.
3. (3) Hatada, H.H.; Lu, X.; Laird, E.R.; Green, J.; Morgenstern, J.P.; Lou, M.; Marr, C.S.; Phillips, T.B.; Ram, M.K.; Theriault, K.; Zoller, M.J. and Karas, J.L. Nature 1995, 377, 32.
4. (4) Burke, Jr. T.R.; Smyth M.S.; Otaka, A.; Nomizu, M.; Roller, P.P.; Wolf, G.; Case, R. and Shoelson, S.E. Biochemistry 1994, 33, 6490.
5. (5) Simon, R.J.; Kania, R.S.; Zuckermann, R.N.; Huebner, V.D.; Jewell, D.A.; Banville, S.; Ng. S.; Wang, L.; Rosenberg, S.: Marlowe, C.K.; Spellmayer, D.; Tan, R.; Frankel, A.D.; Santi, D.V.; Cohen, F.E.; Bartlett, P.A. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 93671.
6. Zuckermann, R.N.; Kerr, J.M.; Kent, S.B.H. and Moos, W.H. J.Amer.Chem.Soc. 1992, 114, 10646.
7. Scott, B.O.; Siegmund, A.C.; Marlowe, C.K.; Pei, Y. and Spear, K.L. Molecular Diversity 1996, 1, 125.
8. -4 M. Seven seconds into the dissociation phase, monitored for 2 min in free buffer flow, report points were taken to generate dose-response curves for estimating IC50 values; ie., the inhibitor concentrations causing a signal decrease of 50 percent. The sensorchip surfaces were very stable and could after sample injection be regenerated using 0.05 % (w/v) SDS.
9. (7) von Bonin, A.; Wienands, J.; Manning, U.; Zuber, J.-F. and Baumann, G. J. Biol. Chem. 1994, 269, 33035.
10. (8) Müller, K.; Gombert, F.; Manning, U.; Grossmüller, F.; Graff, P.; Zaegel, H.; Zuber, J.-F.; Freuler, F.; Tschopp, C. and Baumann, G. J.Biol.Chem. 1996, 271, 16500.
11. (9) Liu, W.-Q.; Carreaux, F.; Meudal, H.; Roques, B.P. and Garbay-Jaureguiberry, C. Tetrahedron 1996, 52, 4411.
12. 3CN/TFA 50/50/0.05 within 15 min. at 60°C, 1 ml/min.) Under these conditions, 8 had a retention time of 9.2 min.